AGTR1 and Duchenne muscular dystrophy: Although there is no direct evidence about RAAS blockade benefits on cardiac tissue remodelling, AT1R inhibition may benefit DMD patients by limiting the amplification of myocardial injury secondary to excessive ROS production in the dystrophic heart.